Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1986 3
1987 1
1988 2
1990 1
1993 2
1995 1
1996 1
1997 2
1998 1
2002 1
2003 1
2004 3
2005 1
2006 1
2007 2
2008 3
2009 1
2010 3
2011 6
2012 2
2014 4
2015 4
2016 1
2017 2
2018 1
2019 2
2020 4
2021 3
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections.
De Clercq E. De Clercq E. Chem Asian J. 2019 Nov 18;14(22):3962-3968. doi: 10.1002/asia.201900841. Epub 2019 Aug 7. Chem Asian J. 2019. PMID: 31389664 Free PMC article. Review.
Eight different compounds, all nucleoside analogues, could presently be considered as potential drug candidates for the treatment of Ebola virus (EBOV) and/or other hemorrhagic fever virus (HFV) infections. ...The C-nucle
Eight different compounds, all nucleoside analogues, could presently be considered as potential drug candidates for the tre
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.
Geraghty RJ, Aliota MT, Bonnac LF. Geraghty RJ, et al. Viruses. 2021 Apr 13;13(4):667. doi: 10.3390/v13040667. Viruses. 2021. PMID: 33924302 Free PMC article. Review.
Among the molecules directly targeting viruses, nucleoside analogues form an essential class of broad-spectrum antiviral drugs. In this review, we will discuss the interest for broad-spectrum antiviral strategies and their limitations, with an emphasis on virus
Among the molecules directly targeting viruses, nucleoside analogues form an essential class of broad-spectrum antiviral drugs …
Hantavirus pulmonary syndrome.
Macneil A, Nichol ST, Spiropoulou CF. Macneil A, et al. Virus Res. 2011 Dec;162(1-2):138-47. doi: 10.1016/j.virusres.2011.09.017. Epub 2011 Sep 17. Virus Res. 2011. PMID: 21945215 Review.
Hantaviruses have a worldwide distribution and are broadly split into the New World hantaviruses, which includes those causing HPS, and the Old World hantaviruses [including the prototype Hantaan virus (HTNV)], which are associated with a different disease, hemor
Hantaviruses have a worldwide distribution and are broadly split into the New World hantaviruses, which includes those causing HPS, a …
New opportunities for field research on the pathogenesis and treatment of Lassa fever.
Khan SH, Goba A, Chu M, Roth C, Healing T, Marx A, Fair J, Guttieri MC, Ferro P, Imes T, Monagin C, Garry RF, Bausch DG; Mano River Union Lassa Fever Network. Khan SH, et al. Antiviral Res. 2008 Apr;78(1):103-15. doi: 10.1016/j.antiviral.2007.11.003. Epub 2007 Dec 17. Antiviral Res. 2008. PMID: 18241935 Review.
Unlike many viral hemorrhagic fevers (VHFs), Lassa fever (LF) is not a rare disease that emerges only as sporadic cases or in outbreak form. ...Although civil unrest in this region over the past two decades has impeded capacity building and research, …
Unlike many viral hemorrhagic fevers (VHFs), Lassa fever (LF) is not a rare disease that emerges only as sporadi …
Highlights in the development of new antiviral agents.
De Clercq E. De Clercq E. Mini Rev Med Chem. 2002 Apr;2(2):163-75. doi: 10.2174/1389557024605474. Mini Rev Med Chem. 2002. PMID: 12370077 Review.
The potential of a large variety of new compounds and new strategies for the treatment of virtually all major virus infections has been addressed. This includes, for the treatment of HIV infections, virus adsorption inhibito …
The potential of a large variety of new compounds and new strategies for the treatment of virtually all major virus
Lassa fever vaccine.
Fisher-Hoch SP, McCormick JB. Fisher-Hoch SP, et al. Expert Rev Vaccines. 2004 Apr;3(2):189-97. doi: 10.1586/14760584.3.2.189. Expert Rev Vaccines. 2004. PMID: 15056044 Review.
Lassa fever remains a serious challenge to public health in West Africa threatening both local residents in rural areas and those who serve them, particularly medical care providers. ...Lassa vaccine initiatives have suffered from a lack of funding in the past but bioterro …
Lassa fever remains a serious challenge to public health in West Africa threatening both local residents in rural areas and those who …
Treatment of Argentine hemorrhagic fever.
Enria DA, Briggiler AM, Sánchez Z. Enria DA, et al. Antiviral Res. 2008 Apr;78(1):132-9. doi: 10.1016/j.antiviral.2007.10.010. Epub 2007 Nov 20. Antiviral Res. 2008. PMID: 18054395 Free PMC article. Review.
Argentine hemorrhagic fever (AHF) is a rodent-borne illness caused by the arenavirus Junin that is endemic to the humid pampas of Argentina. ...However, alternative forms of treatment are called for due to current difficulties in early detection of AHF, relat …
Argentine hemorrhagic fever (AHF) is a rodent-borne illness caused by the arenavirus Junin that is endemic to the humid pampas …
Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries.
Ergonul O. Ergonul O. Curr Opin Virol. 2012 Apr;2(2):215-20. doi: 10.1016/j.coviro.2012.03.001. Curr Opin Virol. 2012. PMID: 22482717 Review.
Crimean-Congo hemorrhagic fever (CCHF) is a fatal viral infection described in Asia, Africa and Europe. ...The clinical features show common dramatic progress characterized by hemorrhage, myalgia, and fever. Besides the direct infection of endothelium, …
Crimean-Congo hemorrhagic fever (CCHF) is a fatal viral infection described in Asia, Africa and Europe. ...The clinical …
New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase.
Fearns R, Deval J. Fearns R, et al. Antiviral Res. 2016 Oct;134:63-76. doi: 10.1016/j.antiviral.2016.08.006. Epub 2016 Aug 27. Antiviral Res. 2016. PMID: 27575793 Free article. Review.
Worldwide, respiratory syncytial virus (RSV) causes severe disease in infants, the elderly, and immunocompromised people. ...In this article, we first provide an overview of the role of the RSV polymerase in viral mRNA transcription and genome replication. We then r …
Worldwide, respiratory syncytial virus (RSV) causes severe disease in infants, the elderly, and immunocompromised people. ...In this …
Use of ribavirin in viruses other than hepatitis C. A review of the evidence.
Ramírez-Olivencia G, Estébanez M, Membrillo FJ, Ybarra MDC. Ramírez-Olivencia G, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2019 Nov;37(9):602-608. doi: 10.1016/j.eimc.2018.05.008. Epub 2018 Jun 12. Enferm Infecc Microbiol Clin (Engl Ed). 2019. PMID: 29907366 Free PMC article. Review.
In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitisC virus. However, there are other diseases in which it could be of benefit and it has the advantage of being suitable for oral, intravenous and inhaled administra …
In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitisC virus. However, there are o …
59 results